CPTII Antibodies

Santa Cruz Biotechnology delivers a wide array of CPTII monoclonal antibodies for research in the field of lipid metabolism and mitochondrial function. CPTII Antibodies are optimized for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carnitine palmitoyltransferase II (CPTII) plays a crucial role in the transport of long-chain fatty acids into the mitochondria for β-oxidation, a vital process for energy production. Deficiencies in CPTII can lead to metabolic disorders, highlighting the significance of studying carnitine palmitoyltransferase II in understanding energy metabolism and related diseases. The study of CPTII is essential for advancing knowledge in metabolic research and therapeutic development. Researchers can utilize CPTII monoclonal antibodies to investigate protein expression patterns and cellular localization. Understanding CPTII function and regulation contributes to developing potential treatments for metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of lipid metabolism and mitochondrial function.